Creativ-Ceutical is an international consulting firm that provides strategic pricing, market access, health economics, and outcomes research services to life sciences companies. They help clients develop pricing and reimbursement strategies, determine clinical and economic value, and select appropriate research methods. Their multidisciplinary team has experience across various therapeutic areas and healthcare systems. Creativ-Ceutical aims to combine strong technical expertise with strategic advice to help clients maximize the value and market access of their products.

1. Strategic Pricing & Market Access,
Health Economics & Outcomes Research
consulting in life sciences

2. Our company
Do you want your
research investment
to produce great returns?
Creative answers to your challenges
Creativ-Ceutical is an international consulting
Market Access is a passage obligé
firm dedicated to supporting the life science
industry and health authorities in strategic
decision making. We provide pricing, market
“ to commercial success. Not integrating
market access early in development
access, health economics and outcomes can seriously jeopardize your return
research services that combine strong technical on investment.
know-how with real strategic expertise.
We have broad experience in the areas of
”
Mondher Toumi, MD - PhD
Founder & President
central nervous system, oncology, vaccines
and rare diseases. These are complex and
developing fields, where treatment paradigms Key Strengths to Serve Your Needs
are in constant evolution and where clinical
and economic issues require rigorous analysis Multidisciplinary skills drawn from industry, academia and agencies
to determine the best choices. With this
Strong understanding of the European healthcare environment,
understanding, we can anticipate issues that with direct access to top-level experts and decision-makers
will arise in other therapeutic domains, and
Growing local presence for deep country insight. Offices in
address even the most difficult challenges. Luxembourg, France, UK, Denmark, Tunisia.
The youth and size of our company gives us
flexibility and encourage innovative thinking,
while our collective experience gives us the A Dedicated and Passionate Team
maturity and perspective to anticipate and
address the real needs of our customers. 40 employees with top qualifications in statistics,
health economics, public health, medicine, econometrics
Published experts, with leading-edge methodology knowledge
A wealth of experience, gained at major pharmaceutical
companies and prestigious European institutions

3. Our services
How can your new product
successfully
access the market?
Pricing, Reimbursement & Market Access Strategy
Market access, the “fourth hurdle” in drug
development, is an inescapable reality for
pharmaceutical, medical device and biotech
companies. No company can expect to succeed
“ Early-stage product profiling from a payer
perspective is a key step towards value creation.
It is not enough to show that your product works;
without designing a pricing and reimbursement payers want to know how well, relative to what
strategy early in the development process. alternative and all this needs projecting 3-5 years
into the future in a dynamic marketplace.
To maximize the value of your product, rely on
our insight and advice from planning to
execution. We work closely with clients to define Adam Plich, MSc
”
a clear path to achieve the best market access PMA Director Associate
conditions, and then deliver the strategic and
technical services to:
Perform pricing research among payers Define market entry strategies to optimise
and stakeholders, including conjoint and reference pricing.
discrete-choice analysis. Build the value story for the core value
Prepare and manage payer discussions at dossier and prepare for HTA.
national and regional levels.
Market Access Value Chain©
Our Market Access Value Chain© identifies the key levers to optimize pricing, reimbursement and access conditions for your product, and
organizes activities into a coherent, integrated plan.

4. Our services
How to best determine
the value of your drug
or device in the real world?
Health Economics & Outcomes Research
Health economics addresses issues related
It is vital to go beyond discussions of technique, to
to scarcity in the allocation healthcare resources.
With limited means, payers must make hard
choices among multiple, different interventions
“ consider the true consequences of our research on
our clients, on patients and on society in general.
to make the best use of available funding. In this Our work definitely has a social dimension.
context, proving value for money is crucial,
but the challenges are many. What is the appro-
Samuel Aballéa, MSc
”
priate comparator? Across what time-frame? Health Economics & Outcomes Research Director
From which perspective? These are just a few
of the questions we help our clients to address.
Outcomes research studies the end results of
Our HEOR solutions
healthcare interventions. With payers looking
beyond efficacy to real-world effectiveness,
demonstrating end results is of increasing Our experts can help you to define and execute health
economic and outcomes research projects in the following areas:
importance to our clients.
Modelling of cost-effectiveness and budgetary impact analysis
To demonstrate to payers that your drug or
Piggyback analysis alongside clinical trials
device improves clinical outcomes enough to
Patient database analyses, e.g. real-life efficacy, compliance, safety
justify funding, we align our technical services
with your strategic needs to ensure that results are Preference elicitation studies
of value to your business. Patient-reported outcome studies
Epidemiological studies
Burden of illness studies
Literature reviews

5. Our services
How to select the most appropriate
methods and develop real insight
that can effectively guide your decisions?
Business Intelligence & Market Research
A product launch plan requires relevant and Creativ-Ceutical is experienced with these and
precise information that feeds each strategic other approaches, and can provide expert
decision. In today's complex life sciences markets, guidance for your development and launch
development decisions require more than simply plans. Our methods apply to:
facts and data. Projections using probabilistic
techniques, simulations, scenario planning and Forecasting and modelling
trade-off analysis are all approaches that can Market value driver identification
improve decision-making. But how to select the
Positioning and messaging research
most appropriate methods and develop real
insight that can effectively guide your choices? Segmentation studies
Portfolio Management & Licensing
Creativ-Ceutical has created a proprietary separately based on this multidimensional
portfolio management tool box to address approach and put in the context of the overall
this challenge using the most suitable analytic portfolio and the company strategy. These
approaches for the decision at hand. We help instruments are based on a Bayesian stochastic
our clients identify the right choices at the right methodology and multi-trait analysis.
time during the development cycle of a drug.
Creativ-Ceutical also provides advisory support
Our portfolio tool enables clients to compute a in the development of licensing strategies, and
risk-revenue curve based on a detailed product can act as a facilitator or as an assessor during
attribute analysis. Any project can be analysed due diligence for acquisitions or divestitures.

6. Luxembourg
33, boulevard du Prince Henri
1724 Luxembourg
France
215, rue du Faubourg Saint-Honoré
75008 Paris
United Kingdom
29/30 Windmill Street
London W1T 2JL
Tunisia
Rue du lac Huron
Résidence Farah
1053 Les Berges Du Lac
Denmark
Fruebjergvej 3
2100 København Ø
©2011 Creativ-Ceutical S.A. All Rights Reserved.